Free Shipping on purchases over €100

Nidina 2, 4 X 800 Gr

Nestlé Nidina 2, 800 g is a powdered milk that contributes to the nutrition of babies from 6 months of age. Its action supports the immune system in the early stages, when the baby is still developing.

SKU: NI3202080920149
Sold out
71.80
€86.60
€22.44
/1kg
Temporarily sold out

Subscribe and we will notify you when it becomes available again.

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7700

Julia Mendoza Murillo

A pharmacist and nutritionist will help you follow healthy lifestyle habits and take care of your health.

Ask me

INFO AND TECHNICAL SPECIFICATIONS

Nestlé Nidina 2, 800 gr is a powdered milk formula developed to contribute to the nutrition of infants from 6 months of age. It is a product that contributes to the development of the immune system.

Nestlé Nidina infant milk is a product without palm oil.

It contains Bifidus lactis, a bifidobacterium that is part of the intestinal flora.

It also contains vitamins C and D, which support the normal function of the body.

Infant milk is also fortified with iron, which supports the development of children's mental abilities.

Iron also supports growth and reduces the risk of infections and diseases.

This powdered formula contains zinc, an essential nutrient that aids growth and supports DNA function.

It supports the formation of cellular proteins.

It contains DHA, which promotes eye and brain development.

In this way, it also supports the cognitive system so that the baby can start to perform its first activities without problems.

The Nestlé Nidina product has a process of proteins that are suitable and necessary for the first months of life.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.